Pan Hu, Li Lei, Ying Wang, Xue Tian, Xia Wei, Ni Jiang, & Lubin Liu. (2023). CLDN4 as a Novel Diagnostic and Prognostic Biomarker and Its Association with Immune Infiltrates in Ovarian Cancer. Hindawi Limited.
Chicago Style (17th ed.) CitationPan Hu, Li Lei, Ying Wang, Xue Tian, Xia Wei, Ni Jiang, and Lubin Liu. CLDN4 as a Novel Diagnostic and Prognostic Biomarker and Its Association with Immune Infiltrates in Ovarian Cancer. Hindawi Limited, 2023.
MLA (9th ed.) CitationPan Hu, et al. CLDN4 as a Novel Diagnostic and Prognostic Biomarker and Its Association with Immune Infiltrates in Ovarian Cancer. Hindawi Limited, 2023.
Warning: These citations may not always be 100% accurate.